Kura Oncology Ownership | Who Owns Kura Oncology?

Overview Forecast RevenueFinancials Chart Transcripts

Kura Oncology Ownership Summary

Kura Oncology is owned by 33.04% institutional investors, 1.45% insiders, and 65.51% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 10.95% of KURA shares. State Street® SPDR® S&P® Biotech ETF is the top mutual fund, with 3.17% of its assets in Kura Oncology shares.

KURA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Kura Oncology	33.04%	1.45%	65.51%
Sector	Healthcare Stocks	35.58%	11.87%	52.55%
Industry	Biotech Stocks	35.75%	11.83%	52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock funding, inc. /de	9.64M	10.95%	$78.35M
Suvretta capital management	8.58M	9.74%	$69.72M
Bvf inc/il	8.45M	9.59%	$68.66M
Blackrock	6.97M	8.30%	$143.43M
Vanguard group	5.51M	6.28%	$57.22M
State street	4.51M	5.12%	$36.68M
Armistice capital	3.74M	4.24%	$30.37M
Prosight management, lp	3.36M	3.81%	$27.29M
Deep track capital, lp	2.64M	3.00%	$21.49M
Aqr capital management	2.12M	2.41%	$17.27M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Alethea capital management	1.53M	6.38%	$12.43M
Prosight management, lp	3.36M	4.48%	$27.29M
Lion point capital, lp	46.00K	2.24%	$373.98K
Bvf inc/il	8.45M	2.19%	$68.66M
Suvretta capital management	8.58M	1.78%	$69.72M
1492 capital management	486.12K	1.50%	$3.95M
Boxer capital	1.00M	1.08%	$20.59M
Artal group	1.82M	0.96%	$37.47M
Nan fung trinity (hk)	1.06M	0.95%	$8.66M
Rangeley capital	101.22K	0.80%	$822.92K

Top Buyers

Holder	Shares	% Assets	Change
Deep track capital, lp	2.64M	0.35%	2.64M
Prosight management, lp	3.36M	4.48%	827.10K
D. e. shaw	1.15M	0.01%	727.99K
Blackrock funding, inc. /de	9.64M	0.00%	626.74K
Vanguard fiduciary trust	554.98K	0.00%	554.98K

Top Sellers

Holder	Shares	% Assets	Change
Deerfield management company, l.p. (series c)	-	-	-5.41M
Paradigm biocapital advisors lp	-	-	-4.33M
Ra capital management	-	-	-4.00M
Ecor1 capital	872.50K	0.37%	-3.33M
Avoro capital advisors	-	-	-2.25M

New Positions

Holder	Shares	% Assets	Change	Value
Deep track capital, lp	2.64M	0.35%	2.64M	$21.49M
Vanguard fiduciary trust	554.98K	0.00%	554.98K	$4.51M
Eversept partners, lp	263.63K	0.16%	263.63K	$2.33M
Martingale asset management l p	117.69K	0.02%	117.69K	$956.85K
Cubist systematic strategies	69.04K	0.00%	69.04K	$611.00K

Sold Out

Holder	Change
Wealthspire advisors	-10.00
Nelson, van denburg & campbell wealth management group	-14.00
Principal securities	-18.00
Main street group	-50.00
Innealta capital	-54.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	122	-44.55%	29,094,977	-65.91%	33	0.35%	62	-53.73%	40	-21.57%
Dec 31, 2025	155	-25.12%	49,542,038	-40.99%	56	0.62%	92	-22.69%	38	-26.92%
Sep 30, 2025	197	7.07%	77,024,381	-6.25%	87	1.00%	112	-0.89%	50	16.28%
Jun 30, 2025	183	-2.14%	82,143,917	5.53%	93	1.18%	112	16.67%	43	-24.56%
Mar 31, 2025	187	-1.06%	80,458,625	1.94%	92	1.12%	97	-19.83%	57	62.86%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
State Street® SPDR® S&P® Biotech ETF	2.81M	3.17%	-27.80K
Vanguard Total Stock Mkt Idx Inv	2.73M	3.07%	-
Vanguard US Total Market Shares ETF	2.17M	2.68%	3.54K
iShares Russell 2000 ETF	1.89M	2.13%	15.93K
HBM Healthcare Investments AG Ord	1.79M	2.01%	100.00K
SPDR® S&P Biotech ETF	1.28M	1.48%	2.86K
Vanguard Institutional Extnd Mkt Idx Tr	981.99K	1.11%	6.48K
Invesco MSCI World ETF	897.58K	1.03%	897.58K
Fidelity Small Cap Index	790.37K	0.89%	8.38K
Great Lakes Disciplined SMidCap	709.95K	0.80%	705.42K

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 21, 2026	Powl Brian T.	Chief Commercial Officer	Sell	$110.00K
May 19, 2026	Powl Brian T.	Chief Commercial Officer	Sell	$3.12K
May 19, 2026	FORD KATHLEEN	Chief Operating Officer	Sell	$20.48K
May 18, 2026	Bair Teresa Brophy	Chief Legal Officer	Sell	$21.16K
Jan 27, 2026	Powl Brian T.	Chief Commercial Officer	Sell	$13.30K

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	4
2026 Q1	-	16
2025 Q4	-	7
2025 Q3	3	6
2025 Q2	-	2

KURA Ownership FAQ

Who Owns Kura Oncology?

Kura Oncology shareholders are primarily institutional investors at 33.04%, followed by 1.45% insiders and 65.51% retail investors. The average institutional ownership in Kura Oncology's industry, Biotech Stocks , is 35.75%, which Kura Oncology falls below.

Who owns the most shares of Kura Oncology?

Kura Oncology’s largest shareholders are Blackrock funding, inc. /de (9.64M shares, 10.95%), Suvretta capital management (8.58M shares, 9.74%), and Bvf inc/il (8.45M shares, 9.59%). Together, they hold 30.28% of Kura Oncology’s total shares outstanding.

Does Blackrock own Kura Oncology?

Yes, BlackRock owns 8.30% of Kura Oncology, totaling 6.97M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 143.43M$. In the last quarter, BlackRock increased its holdings by 66.44K shares, a 0.96% change.

Who is Kura Oncology’s biggest shareholder by percentage of total assets invested?

Alethea capital management is Kura Oncology’s biggest shareholder by percentage of total assets invested, with 6.38% of its assets in 1.53M Kura Oncology shares, valued at 12.43M$.

Who is the top mutual fund holder of Kura Oncology shares?

State Street® SPDR® S&P® Biotech ETF is the top mutual fund holder of Kura Oncology shares, with 3.17% of its total shares outstanding invested in 2.81M Kura Oncology shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools